Please assess the completion status of the following clinical trial:

Trial Title: Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy males and females of non-childbearing potential, 25-55 years of age~* Valid driver's license~Exclusion Criteria:~* Psychiatric disorder~* Recent history of clinically significant neurological disorder, such as seizures, stroke, multiple sclerosis, or head trauma~* Recent histroy or current treatment for sleep disorder

- Gender: ALL
- Minimum Age: 25 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Arm A (Type: EXPERIMENTAL): None
- Arm B (Type: EXPERIMENTAL): None
- Arm C (Type: ACTIVE_COMPARATOR): None
- Arm D (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).